Plus Therapeutics (PSTV) Assets Average (2011 - 2026)

Plus Therapeutics (PSTV) has 16 years of Assets Average data on file, last reported at $18.1 million in Q1 2026.

• Assets Average for Q1 2026 came in at $18.1 million, up 93.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.1 million (up 93.92% YoY), and the FY2025 annual result was $11.5 million, up 27.4% from the prior year.
• Assets Average rose to $18.1 million in Q1 2026 per PSTV's latest filing, from $17.5 million in the prior quarter.
• Over five years, Assets Average peaked at $23.5 million in Q4 2022 and troughed at $6.8 million in Q4 2024.
• A 5-year average of $15.1 million and a median of $14.5 million in 2025 frame the typical range for Assets Average.
• The sharpest annual moves came in 2024 and 2025: Assets Average sank 56.94% in 2024, then jumped 157.11% in 2025.
• A 5-year view of Assets Average shows it stood at $23.5 million in 2022, then tumbled by 47.49% to $12.3 million in 2023, then slumped by 44.82% to $6.8 million in 2024, then surged by 157.11% to $17.5 million in 2025, then advanced by 3.56% to $18.1 million in 2026.
• Business Quant data shows PSTV's Assets Average at $18.1 million in Q1 2026, $17.5 million in Q4 2025, and $14.5 million in Q3 2025.